Table 3 Descriptive statistics for the sample patients by period
| Â | Inpatient sample (n = 27,246) | Outpatient sample (n = 48,282) | ||||
|---|---|---|---|---|---|---|
Mean (SD) | Pre-UZMDP period | Post-UZMDP period | P-value | Pre-UZMDP period | Post-UZMDP period | P-value |
Number of annual visits | 2.05 (1.79) | 1.91 (1.59) | <0.001 | 3.69 (4.15) | 3.82 (4.02) | <0.001 |
Annual aggregate expenditures | 16,881.17 (29,010.76) | 15,679.98 (28,429.88) | 0.001 | 1,274.00 (4,762.41) | 1,377.18 (5,195.01) | 0.023 |
Annual drug expenditures | 4,442.70 (7,808.90) | 7,879.65 (17,259.80) | <0.001 | 213.24 (396.81) | 702.83 (2,939.00) | <0.001 |
Annual diagnosis expenditures | 1,447.27 (4,017.63) | 1,699.53 (4,984.45) | <0.001 | 47.63 (137.76) | 56.73 (153.43) | <0.001 |
Annual laboratory expenditures | 968.76 (1,320.86) | 1,042.90 (1,408.13) | <0.001 | 21.66 (91.28) | 20.18 (83.95) | 0.064 |
Annual medical consumables expenditures | 818.19 (3,172.11) | 890.41 (3,342.08) | 0.067 | 9.81 (110.17) | 15.81 (129.65) | <0.001 |